Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
enabled [disable] Abstract
Number of results

Results found: 2

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  androgenetic alopecia
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
Introduction. Capillaroscopy is a non-invasive imaging method that allows cutaneous microcirculation to be analyzed. During the last decades, a diagnostic and prognostic potential of nailfold capillaroscopy (NVC) has been gaining increasing appreciation. The main indications include Raynaud phenomenon and scleroderma spectrum diseases, however the usefulness of this technique is also suggested in a variety of non-rheumatic diseases. Aim. To assess capillaroscopic patterns in systemic scleroderma (SSc), psoriasis (PV), psoriatic arthritis (PsA), alopecia areata (AA) and androgenetic alopecia. To evaluate serum levels of several endothelial and angiogenic markers, and their relation to capillaroscopic pattern. Material and methods. There were evaluated 295 patients with systemic scleroderma (SSc), psoriasis (PV), psoriatic arthritis (PsA), alopecia areata (AA) and androgenetic alopecia, as well as age- and sex-matched controls, were examined. In each subject, NVC was performed and serum concentration levels of several angiogenic markers. Results. In SSc three NVC patterns: early, active and late were distinguished. Angiopoietin-2 concentrations were higher and andothelial microparticles were lower in patients with late NVC pattern. We found several differences between the NVC pattern in PV and PsA. No correlations between NVC pattern and serum levels of angiogenic markers were revealed. In AA, we distinguished both normal and abnormal NVC patterns, although the normal patterns were more frequent. Branching capillaries and features of neoformation were often present in patients with the abnormal pattern. In androgenetic alopecia, the normal NVC pattern was most frequently present, however, we found several statistically significant capillarosopic alterations, like branching capillaries, features of neoformation and altered distribution of capillaries. Discussion and Conclusions. Serum levels of Ang-2 and EMPs may reflect capillary damage in SSc. NVC pattern varies between PV and PsA patients. The presence of abnormal NVC patterns in alopecia patients might show the role of disturbances in microcirculation in the diseases. Further studies are required to confirm the hypothesis.
EN
The study presents the mechanism of male androgenetic alopecia (MAGA), with a focus on the role of the enzyme 5-α-reductase, which is responsible for converting testosterone, the primary male hormone, into its active form, dihydrotestosterone (DHT). The consequences of the DHT stimulation of androgen receptors (ARs) located in the X chromosome of dermal papilla cells (DPCs) are described. This leads to androgen-induced gene transcription, disrupted hair follicle nourishment, and most importantly, an accelerated transition from the anagen to the catagen phase. The study also discusses how this enzyme can be targeted by molecules acting as inhibitors. Furthermore, the justification for conducting more in-depth studies on the mechanisms of action involving extracts of saw palmetto (Serenoa repens) and their inhibitory effects on 5-α-reductase is presented. The study also advocates the identification and measurement of active substances present in saw palmetto extracts, with two promising phytosterolic compounds, stigmasterol and β-sitosterol, due to their demonstrated inhibitory activity on 5-α-reductase in extracts from other plant species. As part of the proposal to deepen the research, attention is drawn to the need to investigate the impact of saw palmetto extract on the hair growth cycle, hair follicle life cycle, various growth factors and angiogenesis, immune system activity, and oxidative stress. Other areas of observation for the action of saw palmetto extracts could include their use in combination with other plant extracts or therapeutic agents such as platelet-rich plasma or fibrin-rich plasma.
PL
W pracy przedstawiono mechanizm łysienia androgenowego u mężczyzn (male androgenetic alopecia – MAGA) z uwzględnieniem roli enzymu 5-α-reduktazy, która odpowiada za konwersję testosteronu, najważniejszego hormonu męskiego, do jego aktywnej formy – dihydrotestosteronu (DHT). Opisane zostały konsekwencje pobudzenia przez DHT receptorów androgenowych (androgen receptors – ARs), zlokalizowanych w chromosomie X komórek linii brodawkowej (dermal papilla cells – DPCs). Powoduje to transkrypcję genów uruchamianą przez androgeny, zostaje zaburzone odżywianie mieszka włosowego, ale przede wszystkim przyspieszeniu ulega moment zakończenia anagenu i przejścia do fazy katagenu. Przedstawiono również, w jaki sposób enzym ten może być poddawany działaniu molekuł pełniących funkcję jego inhibitorów. Ponadto zaprezentowano uzasadnienie dla prowadzenia bardziej dogłębnych badań poświęconych mechanizmom działania, w których ekstrakty palmy sabałowej (Serenoa repens) wywołują efekt inhibicji 5-α-reduktazy. Dodatkowo w pracy został zawarty postulat na rzecz rozpoznawania i pomiaru substancji aktywnych znajdujących się w ekstraktach palmy sabałowej, w tym dwóch najbardziej obiecujących związków fitosterolowych – stigmasterolu i β-sitosterolu – ze względu na udowodnioną już aktywność inhibitorową w stosunku do 5-α-reduktazy w ekstraktach z surowców pochodzących z innych gatunków roślin. W ramach postulatu na rzecz pogłębienia badań zwrócono uwagę na konieczność oceny wpływu stosowania ekstraktów z palmy sabałowej na cykl życia włosów, cykl życia mieszka włosowego, różne czynniki wzrostu i angiogenezę, a także aktywność układu immunologicznego czy stres oksydacyjny. Inne obszary obserwacji działania ekstraktów z palmy sabałowej mogłyby obejmować ich zastosowanie w terapiach w połączeniu z innymi ekstraktami roślinnymi lub środkami terapii, np. z osoczem bogatopłytkowym czy osoczem bogatym w fibrynę.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.